The Company’s unique technology will be jointly presented by Apis Biotechnology and Sepmag itself, at the conference organised by the Chinese Association for Clinical Laboratory Providers (CACLP), and attended by high level life science audiences from across China. The event is sponsored by the National Association of Health Industry and Enterprise Management and the Chinese Association for Clinical Laboratory Providers. Moreover, the expo is supported by the Chinese Technical Committee of Clinical Laboratory Testing, together with the In Vitro Diagnostics Standardization Administration of China.
This latest development follows-on from the recent patent SEPMAG was awarded from China’s State Intellectual Property Office (SIPO), and marks the Company’s intentions to further expand revenues in China - a market still in its infancy, but forecast by analysts to expand at double digit pace over the coming years. As previously reported, SEPMAG has already commenced shipping the SEPMAG Q250ml to CapitalBio, its first client in the region, for the production of its IVD kits.
SEPMAG CEO, Josep Maria Simó will hold a two hour seminar (complete with live demonstrations) on Apis Biotechnology’s stand, explaining how homogeneous separation techniques will help assist rapid growth amongst the Country’s newly established in vitro diagnostic companies.
“The Chinese government is keen to develop China’s own diagnostics technologies and advance the IVD market within the country. The Chinese market has tremendous growth potential and the company is on the cusp of an explosion of new developments in this field. Using our technologies they will be able to develop more consistent and reliable and safer results with reduced bead aggregation. This will undoubtedly help to facilitate the growth of China’s IVD industry and we look forward to advancing research for the betterment of healthcare in the region” Josep Maria Simó.
About SEPMAG:
SEPMAG develops, manufactures and markets homogenous biomagnetic separation equipment for the international diagnostics market. Its systems enhance the reproducibility of diagnostic kits, reduce material waste, facilitate the validation process and increase the safety of operation. These benefits are applicable through a range of laboratory settings from R&D through to large scale production. The company is headquartered in the Vallès Technology Park, Barcelona and has a U.S. subsidiary in Atlanta (GA).
Our product range includes the Stepmag, Sepmag Q and Sepmag LAB series, as well as the QCR monitoring system to control the process
www.sepmag.eu
About CACLP:
National Association of Health Industry and Enterprise Management (NAHIEM) Chinese Association for Clinical Laboratory Provider (CACLP) are registered with Ministry of Civil Affairs. It is a social association to coordinate the national business activities relevant to clinical laboratory industry, under the leadership of Ministry of Health of PRC. CACLP is dedicated to be an assistant of the health administrative sections to enact policies, laws and regulations, to protect the whole industrial benefits, to organize experience discussion within experts, entrepreneurs etc., to promote the state-of-the-art R&D achievements, to recommend high quality products. CACLP is a bridge to link up all of enterprises in this field. www.caclp.org
About 8th Clinical Laboratory Provider and Blood Transfusion Equipment Expo:
The event is held by National Association of Health Industry and Enterprise Management Chinese Association for Clinical Laboratory Provider (CACLP), at the Xi¡¯an Greenland Pico International Convention & Exhibition Centre, Shanxi province, 8th to 12th March, 2011.
The Expo became the only large exhibition of clinical laboratory in China and it represents the in vitro diagnostic industrial sectors.
March 8th ~ March 9th Registration, Disposition
March 10th ~ March 12th Conference and show
For more information, please contact Tristan Jervis or Alex Heeley on: 00 44 207 861 3019. E-mail: t.jervis@defacto.com
